REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • January 26th, 2007 • Integrated Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • Massachusetts
Registration Rights Agreement (the “Agreement”), dated as of December 22, 2006, by and between Integrated Pharmaceuticals, Inc., a corporation organized under the laws of State of Idaho, with its principal executive office at 310 Authority Drive, Fitchburg, MA 01420 (the “Company”), and Dutchess Private Equities Fund, Ltd., a Cayman Islands exempted company with its principal office at 50 Commonwealth Avenue, Suite 2, Boston, MA 02116 (the “Holder”).
INVESTMENT AGREEMENTInvestment Agreement • January 26th, 2007 • Integrated Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • Massachusetts
INVESTMENT AGREEMENT (this "AGREEMENT"), dated as of December 22, 2006 by and between Integrated Pharmaceuticals, Inc. a Idaho corporation (the "Company"), and Dutchess Private Equities Fund, Ltd. a Cayman Islands exempted Company (the "Investor").
INTEGRATED PHARMACEUTICALS, INC. PLACEMENT AGENT AGREEMENTPlacement Agent Agreement • January 30th, 2007 • Integrated Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • Delaware
The undersigned, Integrated Pharmaceuticals, Inc., a Idaho corporation (the “COMPANY”), hereby agrees with US EURO Securities, Inc. (the “PLACEMENT AGENT”) and Dutchess Private Equities Fund, Ltd., a a Cayman Islands exempted Company (the “INVESTOR”) as follows:
NEC Partnership Westwood, MA 02090 October 13, 2005Integrated Pharmaceuticals Inc • November 15th, 2005 • In vitro & in vivo diagnostic substances
On behalf of NEC Partnership, the Licensor under the above-referenced License, we hereby agree to modify section 5.4 of the License:
FIRST AMENDED AND RESTATED PATENT LICENSE AGREEMENTPatent License Agreement • September 27th, 2004 • Integrated Pharmaceuticals Inc • Massachusetts
Effective as of the 28th day of August, 2004 NEC PARTNERSHIP, (the “Partnership”, or the “Licensor”) having an address of 101 High Street, Westwood, MA 02090, and INTEGRATED PHARMACEUTICALS, INC. ("Licensee"), a corporation duly organized and existing under the laws of Idaho, and having its principal place of business at 310 Authority Drive, Fitchburg, MA 01420, hereby agree as follows:
First Amended and Restated Supply AgreementSupply Agreement • May 12th, 2005 • Integrated Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • Massachusetts
This first amended and restated agreement is entered into as of the 19th day of February 2005 at Chicago, Illinois, USA by and between Integrated PHARMACEUTICALS, INC (hereinafter referred to as “Integrated”) or its representative, an Idaho corporation located at 310 Authority Drive, Fitchburg, Massachusetts 01420 and Fragchem CORPORATION (hereinafter referred to as “Fragchem”), an Illinois corporation with its Registered Office situated at 8809 W. Golf Road #12A, Niles, Illinois 60714.
NEC Partnership Westwood, MA 02090 May 5, 2005Integrated Pharmaceuticals Inc • May 12th, 2005 • In vitro & in vivo diagnostic substances
On behalf of NEC Partnership, the Licensor under the above-referenced License, we hereby agree to modify section 5.4 of the License as follows:
